Clinical Research Directory
Browse clinical research sites, groups, and studies.
Feasibility of Molecular Biology in Pancreatic Cyst Tumors
Sponsor: Hospital St. Joseph, Marseille, France
Summary
The main objective of the study is to compare the diagnostic accuracy of intra-cystic fluid DNA molecular analysis to standard diagnostics. The secondary objective of the study is to evaluate the feasibility of intra-cystic fluid DNA molecular analysis.
Official title: Study of Feasibility and Diagnostic Profitability of Intra-cyst Fluid Molecular Biology Analysis in Pancreatic Cyst Tumors.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
93
Start Date
2017-01
Completion Date
2027-01
Last Updated
2022-04-14
Healthy Volunteers
No
Interventions
Molecular biology analysis of pancreatic intra-cyst fluid
The EUS FNA will be performed according to the Francophone Club of Echo Endoscopy recommendations. For molecular biology technique, the samples will be processed within the UMR\_S910 unit. Nucleic acids will be extracted from the intra-cystic fluid or, for post-operative patients, from a resected specimen that will be collected into a tube containing a nucleic acid stabilization solution (Allprotect Tissue reagent, Qiagen). The nucleic acids will be extracted and then sequenced. The sequencing technology chosen (HaloPlexHS, Agilent) allows a detection close to 1% in allelic frequency. This new technical approach that links high sensitivity and specificity is also suitable with degraded and/or low-volume ( \<50ng) DNA.
Locations (11)
Clinique de Bercy
Charenton-le-Pont, France
Centre Hospitalier Universitaire Dupuytren
Limoges, France
Hopital Edouard Herriot
Lyon, France
Hopital Mermoz
Lyon, France
Hopital Europeen
Marseille, France
Hopital Saint Joseph
Marseille, France
Chu La Timone
Marseille, France
CHU NANTES Institut des Maladies de l'Appareil Digestif
Nantes, France
Chu L'Archet 2
Nice, France
Hopital Saint Joseph
Paris, France
Centre Hospitalier Jacques Lacarin
Vichy, France